TAIWAN · TWSE / TPEx
SLC
松瑞藥 · 4167 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$20.651 month +8.4% · 1 year +29.7%
Directors and supervisors hold23,468,0007.1% of shares issued
Of which pledged0.0%0
Revenue, 2026-09+33.7%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 漢友財務管理顧問股份有限公司 | Chairman | 3,667,555 | 3,916,948 | 1.18% | — | — |
| 李香雲 | Chairman (corporate representative) | — | 338,661 | 0.10% | — | 619 |
| 英屬蓋曼群島商ＳＦＳＶＥＮＴＵＲＥＬＴＤ． | Director | 7,393,448 | 7,896,202 | 2.38% | — | — |
| 鍾信勇 | Director (corporate representative) | — | 0 | — | — | 239,596 |
| 敏駒投資股份有限公司 | Director | 6,241,975 | 6,666,429 | 2.01% | — | — |
| 陳勇發 | Director (corporate representative) | — | 685,226 | 0.21% | — | — |
| 謝榮盛 | Director (corporate representative) | — | 0 | — | — | 10,680 |
| 佳駒投資有限公司 | Director | 4,387,349 | 4,685,688 | 1.41% | — | — |
| 王柏森 | Director (corporate representative) | — | 0 | — | — | — |
| 周家駒 | Director (corporate representative) · Vice president | — | 66,690 | 0.02% | — | — |
| 林志明 | Independent director | — | 0 | — | — | — |
| 鄭欽華 | Independent director | — | 0 | — | — | — |
| 張日炎 | Independent director | 283,458 | 302,733 | 0.09% | — | — |
| 陳志芳 | President | — | 91,688 | 0.03% | — | — |
| 陳逸修 | Vice president | — | 10,680 | 0.00% | — | — |
| 陳銘輝 | Vice president | — | 8,544 | 0.00% | — | — |
| 林彥嵐 | Vice president | — | 80,856 | 0.02% | — | — |
| 林國瑋 | Assistant vice president · Chief financial officer · Chief accountant | — | 8,544 | 0.00% | — | — |